NCT01999647

Brief Summary

This study was designed to assess whether the injection of local anesthetic into the nerve (intraneural), as opposed to around it (perineural), requires a shorter time to develop surgical anesthesia of the lower leg. The investigators will compare the two types of injection using the same drug, so as to determine if there is an actual difference onset time. They will also examine the overall success rate of either kind of sciatic nerve blocks as the sole anesthetic for non-emergent orthopedic surgery. The safety of these procedures will be examined by in-hospital and phone-call follow-up contacts.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
64

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Dec 2011

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2011

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2012

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2012

Completed
12 months until next milestone

First Submitted

Initial submission to the registry

November 25, 2013

Completed
8 days until next milestone

First Posted

Study publicly available on registry

December 3, 2013

Completed
Last Updated

December 4, 2013

Status Verified

December 1, 2013

Enrollment Period

9 months

First QC Date

November 25, 2013

Last Update Submit

December 2, 2013

Conditions

Keywords

Lower ExtremitySciatic NerveAnesthetics, LocalRopivacaineUltrasonography

Outcome Measures

Primary Outcomes (1)

  • Onset Time of Sciatic Nerve Block

    Time to onset of sciatic nerve anesthesia, defined as both following criteria: * Sensory: does not feel pain or discomfort when pricked with a 25G needle. * Motor: able to slightly curl toes; unable to flex the ankle.

    ≤30 minutes after block performance

Secondary Outcomes (3)

  • Success Rate of Sciatic Nerve Blocks

    ≤30 min after block performance

  • Incidence and Prevalence of Neurologic Disturbances

    30 days after anesthesia performance

  • Differences in Time to Resolution of Sciatic Nerve Block

    <12 h

Other Outcomes (1)

  • Extra- vs. Intraneural Minimum Electrical Stimulation Thresholds

    During performance of nerve block (<30 min)

Study Arms (2)

Perineural

ACTIVE COMPARATOR

Patients in this group will receive a perineural injection for subgluteal sciatic nerve block under real-time, short-axis, in-plane ultrasound guidance, in addition to a femoral nerve block and patient-controlled postoperative analgesia. Ropivacaine will be used for the sciatic nerve block, whereas the choice of agent for the femoral nerve block is left to the attending anesthesiologist.

Procedure: Perineural Injection for Subgluteal Sciatic Nerve BlockProcedure: Femoral Nerve BlockProcedure: Patient-Controlled Postoperative AnalgesiaDrug: Ropivacaine

Intraneural

EXPERIMENTAL

Patients in this group will receive an intraneural injection for subgluteal sciatic nerve block under real-time, short-axis, in-plane ultrasound guidance, in addition to a femoral nerve block and patient-controlled postoperative analgesia. Ropivacaine will be used for the sciatic nerve block, whereas the choice of agent for the femoral nerve block is left to the attending anesthesiologist.

Procedure: Intraneural Injection for Subgluteal Sciatic Nerve BlockProcedure: Femoral Nerve BlockProcedure: Patient-Controlled Postoperative AnalgesiaDrug: Ropivacaine

Interventions

The injection will start as the needle penetrates the outermost discernible layer of the nerve (epineurium) under ultrasound guidance. The injection will be adjudicated as "intraneural" if nerve cross section expansion and a reduction in echogenicity are observed. Short-axis real-time ultrasound imaging will be used, with an in-plane needle approach.

Also known as: Injection beneath the common investing extraneural layer, Subepineural Injection, Gluteal sciatic nerve block, Subparaneural injection
Intraneural

The injection will start as the needle indents the outermost discernible layer of the nerve (epineurium) under ultrasound guidance. The injection will be adjudicated as "intraneural" if the drug infiltrates the space between the epimysium of the surrounding muscles and the outer epineurium of the sciatic nerve. Short-axis real-time ultrasound imaging will be used, with an in-plane needle approach.

Also known as: Injection outside the common investing extraneural layer, Epineural injection, Extraneural injection, Injection outside the paraneurium
Perineural

Patients will receive an ultrasound-guided femoral nerve block using a short- or long-acting local anesthetic, as deemed indicated.

IntraneuralPerineural

Patients will receive a patient-controlled intravenous or perineural catheter-based analgesia, depending on their preference and the anesthesiologist's indication.

Also known as: PCA, PCIVA, PCCPNB, Patient-controlled continuous peripheral nerve block
IntraneuralPerineural

Thirty milliliters of 0.75% (wt/vol) ropivacaine will be used for the sciatic nerve block.

Also known as: Local Anesthetic, Naropin, Naropine
IntraneuralPerineural

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Undergoing non-emergent orthopedic procedure of knee, leg, foot with thigh tourniquet
  • ASA Physical Status Class I-III
  • Consenting to surgery under peripheral nerve block anesthesia (sciatic + femoral/saphenous block)

You may not qualify if:

  • Unable to understand or communicate for the purpose of the study
  • Exhibiting any neurological disturbance of the ipsilateral lower extremity
  • Inability to satisfactorily image the sciatic nerve in the opinion of the attending anesthesiologist

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Anesthesia, Critical Care and Pain Medicine - University of Parma

Parma, PR, 43126, Italy

Location

Related Publications (3)

  • Tran DQ, Dugani S, Pham K, Al-Shaafi A, Finlayson RJ. A randomized comparison between subepineural and conventional ultrasound-guided popliteal sciatic nerve block. Reg Anesth Pain Med. 2011 Nov-Dec;36(6):548-52. doi: 10.1097/AAP.0b013e318235f566.

    PMID: 22005661BACKGROUND
  • Andersen HL, Andersen SL, Tranum-Jensen J. Injection inside the paraneural sheath of the sciatic nerve: direct comparison among ultrasound imaging, macroscopic anatomy, and histologic analysis. Reg Anesth Pain Med. 2012 Jul-Aug;37(4):410-4. doi: 10.1097/AAP.0b013e31825145f3.

    PMID: 22609646BACKGROUND
  • Robards C, Hadzic A, Somasundaram L, Iwata T, Gadsden J, Xu D, Sala-Blanch X. Intraneural injection with low-current stimulation during popliteal sciatic nerve block. Anesth Analg. 2009 Aug;109(2):673-7. doi: 10.1213/ane.0b013e3181aa2d73.

    PMID: 19608846BACKGROUND

MeSH Terms

Conditions

Musculoskeletal DiseasesFoot DiseasesLeg InjuriesFoot InjuriesKnee Injuries

Interventions

Passive Cutaneous AnaphylaxisRopivacaineAnesthetics, Local

Condition Hierarchy (Ancestors)

Skin DiseasesSkin and Connective Tissue DiseasesWounds and Injuries

Intervention Hierarchy (Ancestors)

Skin TestsImmunologic TestsClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisInvestigative TechniquesImmunologic TechniquesAntigen-Antibody ReactionsImmune System PhenomenaAnilidesAmidesOrganic ChemicalsAniline CompoundsAminesAnestheticsCentral Nervous System DepressantsPhysiological Effects of DrugsPharmacologic ActionsChemical Actions and UsesSensory System AgentsPeripheral Nervous System AgentsCentral Nervous System AgentsTherapeutic Uses

Study Officials

  • Marco Baciarello, MD

    University of Parma

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor of Anesthesiology, Critical Care and Pain Medicine

Study Record Dates

First Submitted

November 25, 2013

First Posted

December 3, 2013

Study Start

December 1, 2011

Primary Completion

September 1, 2012

Study Completion

December 1, 2012

Last Updated

December 4, 2013

Record last verified: 2013-12

Locations